RITA CURRAN: Open Payments
NPI 1982042370 · CICERO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 33 payments from 15 companies in 2025. Trend: 2023 $783 · 2024 $414 · 2025 $834
Food & beverage: $834
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $141 |
| Neurocrine BioSciences, Inc. | 2 | $91 |
| Janssen Pharmaceuticals, Inc | 2 | $71 |
| Braeburn Inc. | 4 | $69 |
| Alkermes, Inc. | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $61 |
| Teva Pharmaceuticals USA, Inc. | 2 | $58 |
| Indivior Inc. | 2 | $52 |
| ABBVIE INC. | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $43 |
Products named: REXULTI, INGREZZA, INVEGA SUSTENNA, BRIXADI, ARISTADA, CAPLYTA, UZEDY, SUBLOCADE.
Industry payments across NY — which companies pay providers there.
